Ledger.Open graph →
SEC Form D · filed November 3, 2021

EdenRoc Sciences LLC

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

J. Taylor Crandall · Cambridge, MADirectorTodd Dickinson · Cambridge, MADirectorCarlos Bustamante · Cambridge, MADirectorMathew Easterday · Cambridge, MAExecGregory Lucier · Cambridge, MADirectorDavid Sinclair · Cambridge, MADirectorEdward Schulak · Cambridge, MAExec · DirectorLynne R. Rollins · San Diego, CADirectorDaniel R. Hetu, Md, Mba · San Diego, CAExecEckard R. Weber, Md · San Diego, CAExec · DirectorBrent R. Ahrens · San Diego, CADirectorKeith A. Katkin · San Diego, CADirectorBrian T. Slingsby, Md, Phd, Mph · San Diego, CADirectorWilliam R. Harrington, Md, Mba · San Diego, CADirectorEdward I. Weisiger, Jr · Charlotte, NCDirectorJon L. Morris · Charlotte, NCDirectorMichael P. Harrell · Charlotte, NCDirectorPeter W. Lash, Jr · Charlotte, NCExecBeacon GP LLC · Charlotte, NCExec · DirectorSief Khafagi · BEAVERTON, ORDirectorShannon Savage · Venice, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗